Search for: "Astrazeneca"
Results 201 - 220
of 1,244
Sort by Relevance
|
Sort by Date
29 Sep 2020, 5:52 am
The top assignees by the cumulative number of patent filings were Hoffmann-la Roche, AstraZeneca, Pfizer, Janssen Pharmaceuticals, Sanofi, GSK, Takeda, Vertex, Neurosearch, and Novartis. [read post]
20 Sep 2020, 2:48 pm
AstraZeneca Blueprints – Read the full article on the disclosure…” [read post]
17 Sep 2020, 9:05 pm
AstraZeneca has remained tight lipped about the participant’s illness while emphasizing its commitment to industry and regulatory safety standards. [read post]
15 Sep 2020, 9:31 am
Likewise, phase 3 is currently beginning for the AstraZeneca vaccine developed by Oxford University. [read post]
15 Sep 2020, 8:12 am
It could be a good thing that the product’s makers — Oxford University and AstraZeneca — followed medical-scientific protocols and paused their Phase III clinical trial due to a participant’s unexplained illness. [read post]
12 Sep 2020, 8:59 am
A large, United Kingdom-based Phase 2/3 study testing a Covid-19 vaccine being developed by AstraZeneca has been restarted, according to a statement from the company. [read post]
10 Sep 2020, 6:23 pm
In the United States, for example, efforts under Operation Warp Speed include funding provided in the spring for vaccine developers Moderna, AstraZeneca, and Johnson & Johnson (with the latter two using adenovirus vector approaches) to invest in manufacturing. [read post]
9 Sep 2020, 1:26 pm
AstraZeneca has put on hold studies of its vaccine candidate in ... [read post]
9 Sep 2020, 12:19 pm
The drugmaker AstraZeneca, which is running the trial with Oxford University, has refused to explain the nature of the patient’s illness, and it is now reviewing whether the incident was caused by the vaccine or happened by chance. [read post]
25 Aug 2020, 12:26 pm
If the drug is safe and effective for participants, then AstraZeneca will proceed towards late-stage studies. [read post]
17 Aug 2020, 10:03 am
AstraZeneca Pharmaceuticals LP, Civil Action No. 19-2320-RGA (D.Del. [read post]
5 Aug 2020, 11:43 am
Italy, Germany, France, and the Netherlands set up the Inclusive Vaccines Alliance—which other EU countries may join—and signed a €750M contract for 400M doses of the AstraZeneca-Oxford vaccine. [read post]
27 Jul 2020, 2:04 am
., AstraZeneca, Genentech and GlaxoSmithKline to share information about producing the antibody treatments needed to treat COVID-19. [read post]
23 Jul 2020, 6:31 am
Oxford University and AstraZeneca, a global bio-pharmaceutical company, have recently conducted a trial for their prototype vaccine. [read post]
22 Jul 2020, 1:40 pm
Several governments have signed agreements with some of the 24 groups currently testing a coronavirus vaccine on humans, including a promising candidate developed by Oxford university and AstraZeneca, but most other purchasers have refused to reveal the price paid per dose.Read 14 remaining paragraphs | Comments [read post]
21 Jul 2020, 3:08 pm
All three developers — British-Swedish pharmaceutical company AstraZeneca, Chinese firm CanSino Biologics and a collaboration between American pharmaceutical giant Pfizer and German company BioNTech — said individuals inoculated with their vaccines showed similar antibody levels to those who have recovered from COVID-19. [read post]
20 Jul 2020, 2:07 pm
The vaccine candidate, which is being developed by University of Oxford researchers and AstraZeneca, caused no serious side effects for study participants. [read post]
20 Jul 2020, 1:12 pm
Researchers from pharmaceutical giant AstraZeneca* and Oxford University’s Edward Jenner Institute for Vaccine Research announced promising results from a Phase 1/2 study of their COVID-19 vaccine candidate, known as AZD1222. [read post]
14 Jul 2020, 6:52 am
Maria Dahl, Head of Transactions: Oncology Business Development & Licensing, AstraZeneca Edward de Nor, Executive Parter, GHO Capital Johan Verbeeck, Vice President Business Development, Immunology, Janssen Pharmaceutical Companies of Johnson & Johnson Laurence Barker, Partner and CBO, Dementia Discovery Fund SV Heath Investors James West, Director, Results Healthcare You can register for the roundtable by clicking here. [read post]
10 Jul 2020, 8:59 am
By Rachel Sachs, Jacob S. [read post]
